Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)]
Product Sizes
100 ug
AB00103-10-26-100UG
About this Product
- SKU:
- AB00103-10-26
- Additional Names:
- CD340; Metastatic lymph node gene 19 protein (MLN 19); Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; p185HER2; EGFR
- Application:
- ELISA, Flow Cytometry, Immunohistochemistry
- Buffer:
- PBS with 0.02% Proclin 300.
- translate.label.attr.clone:
- 4D5-8 (trastuzumab)
- Clonality:
- Recombinant Monoclonal
- Extra Details:
- THIS IS A RESEARCH-GRADE BIOSIMILAR. NOT FOR HUMAN THERAPY! This recombinant Fab fragement was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Formulation:
- PBS with 0.02% Proclin 300.
- Host:
- Human
- Immunogen:
- A431 cells (human epidermoid carcinoma) (over)expressing EGFR.
- Purification:
- Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.
- Storage Conditions:
- 2-8[o]C Aliquot., -20[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- Absolute Antibody
- Type:
- Antibody: Recombinant Antibodies
- Manufacturer's Data Sheet:Ab00103-10.26
